Abstract:A broad chemical genetics screen in Mycobacterium tuberculosis (Mtb) to identify inhibitors of established or previously untapped targets for therapeutic development yielded compounds (BRD-8000.3 and BRD-9327) that inhibit the essential efflux pump EfpA. To understand the mechanisms of inhibition by these compounds, we determined the structures of EfpA with inhibitors bound at 2.7 - 3.4 Å resolution. Our structures reveal different mechanisms of inhibition for the two inhibitors. BRD-8000.3 binds in a tunnel making contact with the lipid bilayer and extending toward the central cavity to displace the fatty acid chain of a lipid molecule bound in the apo structure, suggesting its blocking of an access route for a natural lipidic substrate, in contrast to its uncompetitive mechanism for the small molecule substrate ethidium bromide which likely enters through an alternative tunnel. Meanwhile, BRD-9327 binds in the outer vestibule without complete blockade of the substrate path to the outside, suggesting its possible inhibition of the dynamical motion necessary for "alternate access" to the two different sides of the membrane, as is characteristic of major facilitator superfamily (MFS) transporters. Both inhibitors may have a role in inhibiting the "alternate access" mechanism that could account for the uncompetitive nature of their efflux of some substrates. Our results explain the basis of the synergy of these inhibitors and their potential for combination in a multi drug strategy for anti-tuberculosis therapy. They also potentially point to a possible function for this essential efflux pump as a lipid transporter. The structures provide a foundation for rational modification of these inhibitors to increase potency.

Structural Basis for the Development of Potential Inhibitors Targeting FadD23 from Mycobacterium Tuberculosis

The Key Roles of Mycobacterium Tuberculosis FadD23 C-terminal Domain in Catalytic Mechanisms

Structural Study of Medium-Long Chain Fatty Acyl-Coa Ligase FadD8 from Mycobacterium Tuberculosis

Recombinant Expression and Functional Characterization of FadD2 Protein in Mycobacterium Tuberculosis.

Structure based virtual screening and discovery of novel inhibitors against FabD protein of Mycobacterium tuberculosis

Structural basis for the broad substrate specificity of two acyl-CoA dehydrogenases FadE5 from mycobacteria.

Structure and function of Mycobacterium tuberculosis EfpA as a lipid transporter and its inhibition by BRD-8000.3

Structural enzymological studies of the long chain fatty acyl-CoA synthetase FadD5 from the operon of

Structure and inhibition mechanisms of Mycobacterium tuberculosis essential transporter efflux protein A

A Novel Acyl-AcpM-Binding Protein Confers Intrinsic Sensitivity to Fatty Acid Synthase Type II Inhibitors in Mycobacterium smegmatis

Molecular Basis for the Inhibition of Β-Hydroxyacyl-acp Dehydratase HadAB Complex from Mycobacterium Tuberculosis by Flavonoid Inhibitors

Structure-based Design of Anti-Mycobacterial Drug Leads That Target the Mycolic Acid Transporter MmpL3

Identification of Serine 119 As an Effective Inhibitor Binding Site of M. Tuberculosis Ubiquitin-like Protein Ligase PafA Using Purified Proteins and M. Smegmatis.

Crystal Structures of FadD32 and Pks13-Acp Domain from Corynebacterium Diphtheriae

Structures of the Mycobacterium tuberculosis efflux pump EfpA reveal the mechanisms of transport and inhibition

HadBD dehydratase from Mycobacterium tuberculosis fatty acid synthase type II: A singular structure for a unique function

Structure-Based Screening and Optimization of PafA Inhibitors with Potent Anti-Tuberculosis Activity

Structural and functional characterization of FabG4 from Mycolicibacterium smegmatis

Unraveling Structural Disparities in Human and Mycobacterium Tuberculosis Type-I Fatty Acid Synthase

Discovery of a novel dehydratase of the fatty acid synthase type II critical for ketomycolic acid biosynthesis and virulence of Mycobacterium tuberculosis

Structural characterization of the Mycobacterium tuberculosis biotin biosynthesis enzymes 7,8-diaminopelargonic acid synthase and dethiobiotin synthetase